Suc-[Glu9, Ala11,15]-Endothelin-1 (8-21)

Code:
4285-v
Name:
Suc-[Glu9, Ala11,15]-Endothelin-1 (8-21)
IRL 1620
Suc-Asp-Glu-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp (Suc: Succinyl)
(M.W. 1820.9) C86H117N17O27
ETB Receptor Selective Agonist
Package Price(Yen) Availability Quantity  
Vial 0.5 mg 13,000 Ships within
1-3 business days
バルク見積もり

main

Purity:
≧99.0% (HPLC)
Storage:
-20 ℃
Production:
Synthetic Product

Solubility: H2O (0.1 mM)

more information

Category:
Biologically Active Peptides

reference

  1. M. Takai, I. Umemura, K. Yamasaki, T. Watakabe, Y. Fujitani, K. Oda, Y. Urade, T. Inui, T. Yamamura, and T. Okada, Biochem. Biophys. Res. Commun., 184, 953 (1992). (Original)
  2. S.S. Shetty, T. Okada, R.L. Webb, D. DelGrande, and R.W. Lappe, Biochem. Biophys. Res. Commun., 191, 459 (1993). (Pharmacol.)
  3. W.G. Haynes, A.P. Davenport, and D.J. Webb, Trends Pharmacol. Sci., 14, 225 (1993). (Meeting Report; 3rd Int, Conf. Endothelin)
  4. A.F. James, Y. Urade, R.L. Webb, H. Karaki, I. Umemura, Y. Fujitani, K. Oda, T. Okada, R.W. Lappe, and M. Takai, Cardiovasc. Drug Rev., 11, 253 (1993). (Review)
  5. M. Yanagisawa and T. Masaki, Trends Pharmacol. Sci., 10, 374 (1989). (Review)
  6. T. Sakurai, M. Yanagisawa, and T. Masaki, Trends Pharmacol. Sci., 13, 103 (1992). (Review)
  7. A.F. James, Y. Urade, R.L. Webb, H. Karaki, I. Umemura, Y. Fujitani, K. Oda, T. Okada, R.W. Lappe, and M. Takai, Cardiovasc. Drug Rev., 11, 253 (1993). (Review)

関連書類

PDF SDS:
Japanese / English

他の製品を検索する
商品へのこだわり
当社の技術


Scroll to top